Risperdal

Risperdal Legal Recourse: The Johnson and Johnson Study

Published on August 28, 2015 by

By 2003, multiple research studies indicating that Risperdal might be dangerous for patients, especially children, began drawing negative attention to Janssen and its marketing practices. In response, parent company Johnson & Johnson published a paper entitled "Prolactin levels during long-term Risperidone treatment in children and adolescents." The paper stated ...

Published in Risperdal
Continue reading...

Risperdal Legal Recourse: How was Risperdal Marketed to Children?

Published on August 21, 2015 by

In our previous post we explored the history of the Risperdal’s development by the pharmaceutical company Janssen. Now let’s talk about how Janssen marketed Xarelto to children and adolescents without thoroughly testing the drug on this age group.

Although the drug was initially marketed to adults, Janssen has ...

Published in Risperdal
Continue reading...

Risperdal Side Effects: Your Legal Recourse

Published on August 14, 2015 by

The evidence in the previous section clearly suggests that taking Risperdal can lead to serious side effects, particularly hyperprolactinemia and gynecomastia. However, can Janssen Pharmaceuticals (and parent company Johnson & Johnson) really be held responsible for these issues? Did they know about these risks when they promoted ...

Published in Risperdal
Continue reading...